Should Direct to Consumer Advertisements (DTCA) of Prescription Drugs Remain Banned in Malaysia?

Abstract

Advertisements for prescription drugs directed at consumers can empower consumers by providing information on potential treatments for their ailments. Ideally, this information may also enable them to make informed decisions, lead to an early diagnosis or treatment of illnesses, or assist in their discussions with physicians. It has been argued, however, that information in such advertisements is, among other things, biased, misleading and causes unnecessary medication. Such advertising is currently prohibited in Malaysia. It is, however, permitted in the United States of America, New Zealand, and Canada, although under different constraints. This article explores the benefits and the detriments of advertising prescription drugs directly to consumers. It also examines the existing regulatory control of medicines in Malaysia and argues that Malaysia, should maintain its existing approach.